Narang Hong

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Real-World Effectiveness and Safety of Abrocitinib in Patients with Atopic Dermatitis: A 16-Week Single-Center Retrospective Cohort Study Compared with Upadacitinib and Baricitinib.

Real-World Effectiveness and Safety of Abrocitinib in Patients with Atopic Dermatitis: A 16-Week Single-Center Retrospective Cohort Study Compared with Upadacitinib and Baricitinib.

Journal: Dermatology and therapy
Published: December 10, 2025

Baricitinib for Itch-Dominant Atopic Dermatitis: A 52-week Baricitinib Real-World Experience in Korea.

Baricitinib for Itch-Dominant Atopic Dermatitis: A 52-week Baricitinib Real-World Experience in Korea.

Journal: Annals of dermatology
Published: November 10, 2025

Real-World Efficacy and Safety of Upadacitinib in Korean Patients With Atopic Dermatitis.

Real-World Efficacy and Safety of Upadacitinib in Korean Patients With Atopic Dermatitis.

Journal: Allergy, asthma & immunology research
Published: September 08, 2025

Successful Treatment with Upadacitinib of Patient with Persistent Head and Neck Atopic Dermatitis Refractory to Dupilumab: A Case Report.

Successful Treatment with Upadacitinib of Patient with Persistent Head and Neck Atopic Dermatitis Refractory to Dupilumab: A Case Report.

Journal: Indian journal of dermatology
Published: June 06, 2024

Detecting T-cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab.

Detecting T-cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 06, 2023

Atopic dermatitis treated safely with dupilumab during pregnancy and lactation: A case series of four patients.

Atopic dermatitis treated safely with dupilumab during pregnancy and lactation: A case series of four patients.

Journal: The Australasian journal of dermatology
Published: July 07, 2023

Severely pruritic mycosis fungoides successfully treated with upadacitinib.

Severely pruritic mycosis fungoides successfully treated with upadacitinib.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: December 19, 2022

Successful treatment of atopic dermatitis refractory to dupilumab with baricitinib.

Successful treatment of atopic dermatitis refractory to dupilumab with baricitinib.

Journal: Dermatologic therapy
Published: August 08, 2022

Baricitinib rapidly relieves eczema associated pruritus in elderly patients.

Baricitinib rapidly relieves eczema associated pruritus in elderly patients.

Journal: Dermatologic therapy
Published: June 07, 2022

The effect of baricitinib add-on therapy in atopic dermatitis patients treated with dupilumab.

The effect of baricitinib add-on therapy in atopic dermatitis patients treated with dupilumab.

Journal: Dermatologic therapy
Published: February 25, 2022

Very Early Patch Stage of AIDS-related Kaposi Sarcoma: A Case Report.

Very Early Patch Stage of AIDS-related Kaposi Sarcoma: A Case Report.

Journal: Annals of dermatology
Published: January 24, 2022

Tuberculous Lymphadenitis in a Patient Treated with Dupilumab: A Case Report.

Tuberculous Lymphadenitis in a Patient Treated with Dupilumab: A Case Report.

Journal: Annals of dermatology
Published: October 21, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026